Close Menu

NEW YORK – Becton Dickinson reported on Thursday that its fiscal fourth quarter revenues increased approximately 4 percent year over year driven by SARS-CoV-2 test sales.

For the three months ended Sept. 30, the Franklin Lakes, New Jersey company posted revenues of $4.78 billion compared to $4.58 billion in the year-ago quarter, and above the analysts' average estimate of $4.48 billion. On a currency-neutral basis, Q4 revenues increased about 4 percent over the prior year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.